aPrincess Máxima Center for Pediatric Oncology, Utrecht
bDepartment of Clinical Chemistry, Erasmus University Medical Center
cDepartment of Pediatric Oncology/Hematology, Erasmus Medical Center-Sophia’s Children’s Hospital, Rotterdam
dDepartment of Clinical Chemistry, Academic Medical Center (AMC)
eDepartment of Clinical Chemistry, VU Medical Center, Amsterdam
fDepartment of Pediatric Oncology, Beatrix Children’s Hospital, University of Groningen, University, Medical Center Groningen, Groningen, The Netherlands
gInstitute of the Pharmacology of Natural Products and Clinical Pharmacology, University Hospital, Ulm
hDepartment for Pediatric Oncology and Immunology, University Hospital for Children and Adolescents, Erlangen, Germany
Correspondence to Sandra G. Heil, PhD, Department of Clinical Chemistry, Erasmus University Medical Center, Wytemaweg 80, 3015 CN Rotterdam, The Netherlands Tel: +31 10 703 2433; fax: +31 10 704 4895; e-mail: [email protected]
Received February 5, 2018
Accepted July 25, 2018
